Buffett may have paid a premium for some of his recent purchases, but these defensive, high-quality names can generate cash flow growth for decades to come, says Morningstar's Josh Peters.
Morningstar's Gregg Warren, one of three analysts who will be quizzing Warren Buffett and Charlie Munger in Omaha, describes how he narrows down his list of questions to just six.
After updating our projections for Berkshire's businesses and accounting for the deals announced this year, we've raised the firm's fair value estimate by 7%.
Morningstar's Vincent Lui, Andy Bischof and Jeremy Glaser blog from the Berkshire Hathaway Annual Meeting in Omaha.
Pharmacy benefit managers aren't household names, but recent consolidation in the industry is proving out the power of scale for these firms, says Morningstar's Matt Coffina.
The diverse deals completed over the last year show Berkshire still has an appetite to put its cash hoard to work, says Morningstar's Gregg Warren.
Morningstar's Gregg Warren discusses potential successors to Warren Buffett and how Berkshire might change after his departure.
Weather, imports/exports, and the energy situation weighed on first-quarter GDP, but the year-over-year quarterly improvement was among the best we've seen in the recovery, says Morningstar's Bob Johnson.
We bring Berkshire to you with our on-the-spot meeting coverage.
The industrial distributor--a recent addition to the Morningstar DividendInvestor portfolio--has plenty of headroom for earnings and dividend growth, says Morningstar's Josh Peters.